European Pharmaceutical Review

JANUARY 26, 2023

These concentration measurements are used as part of regulatory decisions regarding the safety and efficacy of medicinal products. The US Food and Drug Administration (FDA) implementation date was 7 November 2022. The post EMA publishes updated Q&A for ICH M10 appeared first on European Pharmaceutical Review.

Food and Drug Administration 85

Food and Drug Administration Medicine Pharmaceutical products Pharmaceutical 85

European Pharmaceutical Review

DECEMBER 4, 2023

To address these issues, companies should adopt more advanced production strategies such as continuous flow chemistry, as they can shorten manufacturing processes, increase productivity and throughput. The result is efficient, cost-effective and high-quality (bio)pharmaceutical production. principles.

Pharmaceutical manufacturing 87

Pharmaceutical manufacturing Manufacturing Pharmaceutical Pharmaceutical products 87

European Pharmaceutical Review

JANUARY 16, 2023

This Q&A covers the key developments in pharmaceutical microbiology in 2022, featuring insight from pharmaceutical microbiology experts: Dr Tim Sandle, Head of Microbiology, Bio Products Laboratory Limited. Regulation, particularly Annex 1, was identified as a key focus for 2022.

Pharmaceutical 125

Pharmaceutical Food and Drug Administration Manufacturing FDA 125

PM360

DECEMBER 20, 2023

Given China’s status as the world’s second most populous nation and an economic powerhouse, it represents both a monumental market opportunity and a dynamic arena of challenges for pharmaceutical products. From 2017 to 2022, the Chinese market witnessed a growth rate of 5.3%, compared to the average market growth of 6.6%

Marketing 105

Marketing Insurance Medical Manufacturing 105

Clarivate

MARCH 14, 2024

Nitrosamines have garnered significant attention from the pharmaceutical industry due to their detection in commonly prescribed medications for conditions like type 2 diabetes, high blood pressure, and heartburn. [1] Manufacturers, healthcare providers, and consumers alike face the need to quickly adapt.

Pharmaceutical 52

Pharmaceutical Manufacturing Food Healthcare Provider 52

PharmaKinnex

AUGUST 23, 2022

August 23, 2022. The pharmaceutical industry of 2022 is very different from the space that we all knew in 2012, 2016, or even 2020. PharmaKinnex has spent more than 18 years helping companies adopt new strategies, increase profitability, and expand their product reach. More convenience and safety?

Pharma 52

Pharma Sales Sales Strategy Marketing 52

European Pharmaceutical Review

DECEMBER 19, 2023

TRS 953 – Annex 2, Appendix 1: Stability testing of active pharmaceutical ingredients and finished pharmaceutical products: Stability conditions for WHO Member States by Region. Injection Safety Fact Sheet. References What percentage of the world population lives in developing countries? Internet] Burak. cited 2023July].

Distribution 97

Distribution Manufacturing Food Specialization 97